Earnings ·
Reports Q3 revenue of $150.7M, raises full-year guidance to $625M-$635M
TXG10x Genomics, Inc.
10x Genomics reported third-quarter revenue of $150.7 million, a 1% increase from the prior year period, driven by strength in consumables and the start of commercial shipments for its Atera platform. The company raised its full-year 2026 revenue guidance to $625 million–$635 million, up from the previous range of $610 million–$630 million. Gross margin improved to 75% from 67%, while operating loss narrowed to $16.1 million from $32.2 million as operating expenses decreased by 3%. The life science technology company builds integrated research solutions, including instruments and consumables for single cell and spatial biology.